secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2022-07-14T23:59:59+00:00
Accession:  0001193125-22-193376
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD terminates Merger Agreement; debt maturity extended to July 24; evaluating Chapter 11
--------------------------------------------------------------------------------

- Tender offer at $10/share expired July 12 without acquiring required majority; Merger Agreement terminated July 13.
- Debt maturity under Financing Agreement extended to July 24, 2022; Company paid $1.2M paid-in-kind amendment fee.
- Board evaluating all options including potential refinancing and Chapter 11 filing; normal operations continue during evaluation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312522193376/0001193125-22-193376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312522193376/d338419d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-193376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer